All artemisinin articles
-
NewsStudy provides first evidence of African children with severe malaria experiencing partial resistance to world’s most powerful malaria drug
A new study from Uganda provides the first evidence to date that resistance to a lifesaving malaria drug may be emerging in the group of patients that accounts for most of the world’s malaria deaths: young African children suffering from serious infections.
-
NewsNew agent effective against drug-resistant malaria parasites
Scientists have developed a promising new antimalarial agent, DIF-1(+3), which is a derivative of Dictyostelium differentiation-inducing factor-1 (DIF-1).
-
NewsBreakthrough research identifies mechanism behind drug resistance in malaria parasite
A new study has found that a cellular process called transfer Ribonucleic acid (tRNA) modification influences the malaria parasite’s ability to develop resistance to Artemisinin-based combination therapies.
-
NewsResearchers develop new approaches in the fight against drug resistance in malaria
Researchers have combined the anti-malaria drug artemisinin with coumarin, which, like artemisinin, is also found in plants, and developed an auto-fluorescent compound from both bioactive substances.
-
NewsMainstay malaria drug may be beginning to fail in the Horn of Africa
In eastern Africa, malaria parasites have developed resistance to artemisinins, the backbone of current treatment regimens, a development that could dramatically worsen malaria’s impact if partner drugs fail in the future.
-
NewsMalaria parasites resistant to treatment and detection emerge in Ethiopia
Genomic surveillance by scientists has revealed mutations in malaria-causing parasites that will complicate efforts to eradicate the disease in Africa.
-
NewsDrugs targeting malaria in Mozambique are still effective
The drugs used to treat and prevent malaria in Mozambique are still effective, according to a genomic analysis of drug resistance markers in Plasmodium falciparum, carried out by the Barcelona Institute for Global Health (ISGlobal) and the Manhiça Health Research Center (CISM). Source: CDC/ Dr. Mae Mellvin Photomicrograph ...
